These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8233496)

  • 1. Audiologic monitoring for ototoxicity.
    Campbell KC; Durrant J
    Otolaryngol Clin North Am; 1993 Oct; 26(5):903-14. PubMed ID: 8233496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Research progress on mechanism of cisplatin ototoxicity and protective agents against the ototoxic effects].
    Liao YJ; Tang H
    Sheng Li Ke Xue Jin Zhan; 2003 Jul; 34(3):266-9. PubMed ID: 14628479
    [No Abstract]   [Full Text] [Related]  

  • 4. Initial audiologic assessment of infants referred from well baby, special care, and neonatal intensive care unit nurseries.
    Karzon RK; Lieu JE
    Am J Audiol; 2006 Jun; 15(1):14-24. PubMed ID: 16803788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An efficient test protocol for identification of a limited, sensitive frequency test range for early detection of ototoxicity.
    Vaughan NE; Fausti SA; Chelius S; Phillips D; Helt W; Henry JA
    J Rehabil Res Dev; 2002; 39(5):567-74. PubMed ID: 17642021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening strategies for neonatal hearing loss: which test is best?
    Dort JC; Tobolski C; Brown D
    J Otolaryngol; 2000 Aug; 29(4):206-10. PubMed ID: 11003070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newborn hearing screening by transient evoked otoacoustic emissions: analysis of response as a function of risk factors.
    De Capua B; De Felice C; Costantini D; Bagnoli F; Passali D
    Acta Otorhinolaryngol Ital; 2003 Feb; 23(1):16-20. PubMed ID: 12812130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of distortion-product otoacoustic emissions-based ototoxicity monitoring using various primary frequency step-sizes.
    McMillan GP; Konrad-Martin D; Dille MF
    Int J Audiol; 2012 Sep; 51(9):689-96. PubMed ID: 22676700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Auditory neuropathy: three cases among a group with sensorineural hearing loss.
    Mohd Khairi MD; Normastura AR; Wan Zaharah AW
    Singapore Med J; 2009 Sep; 50(9):e324-5. PubMed ID: 19787161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of high-dose cisplatin on auditory brainstem responses and otoacoustic emissions in laboratory animals.
    Sockalingam R; Freeman S; Cherny TL; Sohmer H
    Am J Otol; 2000 Jul; 21(4):521-7. PubMed ID: 10912698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions.
    Knight KR; Kraemer DF; Winter C; Neuwelt EA
    J Clin Oncol; 2007 Apr; 25(10):1190-5. PubMed ID: 17401008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using otoacoustic emissions to screen for hearing loss in early childhood care settings.
    Eiserman WD; Hartel DM; Shisler L; Buhrmann J; White KR; Foust T
    Int J Pediatr Otorhinolaryngol; 2008 Apr; 72(4):475-82. PubMed ID: 18276019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cochlear hearing disorders: normative distortion product otoacoustic emission measurements.
    Mills DM; Feeney MP; Gates GA
    Ear Hear; 2007 Dec; 28(6):778-92. PubMed ID: 17982366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vestibular ototoxicity. Clinical considerations.
    Black FO; Pesznecker SC
    Otolaryngol Clin North Am; 1993 Oct; 26(5):713-36. PubMed ID: 8233485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Difficulties and peculiarities of diagnosis of hearing disorders in premature infants with perinatal pathology].
    Rakhmanova IV; Bogomil'skiĭ MR; Lazarevich AA; Sapozhnikov IaM
    Vestn Otorinolaringol; 2009; (2):14-6. PubMed ID: 19491790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Objective audiological diagnosis].
    Rahne T; Plontke S
    Laryngorhinootologie; 2012 Oct; 91(10):649-64, quiz 665-6. PubMed ID: 23011667
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening for hearing loss and middle-ear effusion in school-age children, using transient evoked otoacoustic emissions: a feasibility study.
    Georgalas C; Xenellis J; Davilis D; Tzangaroulakis A; Ferekidis E
    J Laryngol Otol; 2008 Dec; 122(12):1299-304. PubMed ID: 18423079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability of hearing screening in high-risk neonates: comparative study of otoacoustic emission, automated and conventional auditory brainstem response.
    Suppiej A; Rizzardi E; Zanardo V; Franzoi M; Ermani M; Orzan E
    Clin Neurophysiol; 2007 Apr; 118(4):869-76. PubMed ID: 17317296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A combined neonatal hearing screening protocol].
    Almenar Latorre A; Tapia Toca MC; Fernández Pérez C; Moro Serrano M
    An Esp Pediatr; 2002 Jul; 57(1):55-9. PubMed ID: 12139894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in transient-evoked otoacoustic emission levels with negative tympanometric peak pressure in infants and toddlers.
    Prieve BA; Calandruccio L; Fitzgerald T; Mazevski A; Georgantas LM
    Ear Hear; 2008 Aug; 29(4):533-42. PubMed ID: 18469719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.